Condition: Hyperammonemia · Methylmalonic Acidemia · Propionic Acidemia · Sponsor: RECORDATI GROUP
To obtain short-term and long-term clinical safety information, in pediatric and adult patients with PA and MMA treated with Carbaglu®.
This description comes directly from the study's public registry record.
Anne Marie Cesario · 908-849-4907 · cesario.a@recordati.com
Always discuss trial participation with your own doctor first.
| Children's National Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Recruiting |
| Riley Children's Hospital | Indianapolis, Indiana, United States | Recruiting |
| Icahn School of Medicine at Mt. Sinai | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05040178